101 related articles for article (PubMed ID: 25307412)
1. Establishment and characterization of metastatic gastric cancer cell lines from murine gastric adenocarcinoma lacking Smad4, p53, and E-cadherin.
Park JW; Park DM; Choi BK; Kwon BS; Seong JK; Green JE; Kim DY; Kim HK
Mol Carcinog; 2015 Nov; 54(11):1521-7. PubMed ID: 25307412
[TBL] [Abstract][Full Text] [Related]
2. Cooperativity of E-cadherin and Smad4 loss to promote diffuse-type gastric adenocarcinoma and metastasis.
Park JW; Jang SH; Park DM; Lim NJ; Deng C; Kim DY; Green JE; Kim HK
Mol Cancer Res; 2014 Aug; 12(8):1088-99. PubMed ID: 24784840
[TBL] [Abstract][Full Text] [Related]
3. Stem Cells Antigen-1 Enriches for a Cancer Stem Cell-Like Subpopulation in Mouse Gastric Cancer.
Park JW; Park JM; Park DM; Kim DY; Kim HK
Stem Cells; 2016 May; 34(5):1177-87. PubMed ID: 26869189
[TBL] [Abstract][Full Text] [Related]
4. Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice.
Park JW; Kim MS; Voon DC; Kim SJ; Bae J; Mun DG; Ko SI; Kim HK; Lee SW; Kim DY
Mol Carcinog; 2018 Jul; 57(7):947-954. PubMed ID: 29528141
[TBL] [Abstract][Full Text] [Related]
5. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
[TBL] [Abstract][Full Text] [Related]
6. Smad4 and p53 synergize in suppressing autochthonous intestinal cancer.
Park JW; Seo MJ; Cho KS; Kook MC; Jeong JM; Roh SG; Cho SY; Cheon JH; Kim HK
Cancer Med; 2022 May; 11(9):1925-1936. PubMed ID: 35274815
[TBL] [Abstract][Full Text] [Related]
7. Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations.
Seidlitz T; Chen YT; Uhlemann H; Schölch S; Kochall S; Merker SR; Klimova A; Hennig A; Schweitzer C; Pape K; Baretton GB; Welsch T; Aust DE; Weitz J; Koo BK; Stange DE
Gastroenterology; 2019 Dec; 157(6):1599-1614.e2. PubMed ID: 31585123
[TBL] [Abstract][Full Text] [Related]
8. Proteogenomic analysis of NCC-S1M, a gastric cancer stem cell-like cell line that responds to anti-PD-1.
Park JW; Um H; Yang H; Ko W; Kim DY; Kim HK
Biochem Biophys Res Commun; 2017 Mar; 484(3):631-635. PubMed ID: 28153736
[TBL] [Abstract][Full Text] [Related]
9. Wnt pathway is involved in advanced gastric carcinoma.
Zhang H; Xue Y
Hepatogastroenterology; 2008; 55(84):1126-30. PubMed ID: 18705344
[TBL] [Abstract][Full Text] [Related]
10. FAT4 functions as a tumour suppressor in gastric cancer by modulating Wnt/β-catenin signalling.
Cai J; Feng D; Hu L; Chen H; Yang G; Cai Q; Gao C; Wei D
Br J Cancer; 2015 Dec; 113(12):1720-9. PubMed ID: 26633557
[TBL] [Abstract][Full Text] [Related]
11. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.
Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H
Cancer Res; 2007 May; 67(9):4079-87. PubMed ID: 17483318
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis.
Milne AN; Sitarz R; Carvalho R; Polak MM; Ligtenberg M; Pauwels P; Offerhaus GJ; Weterman MA
Hum Pathol; 2007 Jun; 38(6):903-13. PubMed ID: 17376510
[TBL] [Abstract][Full Text] [Related]
13. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M
Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573
[TBL] [Abstract][Full Text] [Related]
14. Krüppel-like factor 4 negatively regulates β-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer.
Zhang N; Zhang J; Shuai L; Zha L; He M; Huang Z; Wang Z
Int J Oncol; 2012 Jun; 40(6):2038-48. PubMed ID: 22407433
[TBL] [Abstract][Full Text] [Related]
15. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type.
Hidaka Y; Mitomi H; Saito T; Takahashi M; Lee SY; Matsumoto K; Yao T; Watanabe S
Hum Pathol; 2013 Nov; 44(11):2438-48. PubMed ID: 24011952
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.
Cui J; Xi H; Cai A; Bian S; Wei B; Chen L
Int J Mol Med; 2014 Jul; 34(1):197-204. PubMed ID: 24788044
[TBL] [Abstract][Full Text] [Related]
17. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
18. The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC.
Voorneveld PW; Kodach LL; Jacobs RJ; van Noesel CJ; Peppelenbosch MP; Korkmaz KS; Molendijk I; Dekker E; Morreau H; van Pelt GW; Tollenaar RA; Mesker W; Hawinkels LJ; Paauwe M; Verspaget HW; Geraets DT; Hommes DW; Offerhaus GJ; van den Brink GR; Ten Dijke P; Hardwick JC
Br J Cancer; 2015 Jan; 112(1):122-30. PubMed ID: 25393365
[TBL] [Abstract][Full Text] [Related]
19. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
20. Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity.
Voon DC; Wang H; Koo JK; Nguyen TA; Hor YT; Chu YS; Ito K; Fukamachi H; Chan SL; Thiery JP; Ito Y
Stem Cells; 2012 Oct; 30(10):2088-99. PubMed ID: 22899304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
